Literature DB >> 3771814

Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.

M H Pollack, G E Tesar, J F Rosenbaum, S A Spier.   

Abstract

Fifty patients with panic disorder or agoraphobia with panic attacks with treated with clonazepam, a high potency benzodiazepine. The authors report on the outcome of these patients after an average follow-up interval of 1 year, suggesting that clonazepam is a safe, effective, and easy to administer medication in a relatively treatment-refractory population of nondepressed patients with panic disorder and agoraphobia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771814

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

Review 1.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 2.  Overview of panic disorder.

Authors:  J C Ballenger
Journal:  Trans Am Clin Climatol Assoc       Date:  1994

3.  Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat.

Authors:  D J Fontana; T J Carbary; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Benzodiazepines: more "behavioural" addiction than dependence.

Authors:  Carlos de las Cuevas; Emilio Sanz; Juan de la Fuente
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

5.  Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder?

Authors:  D J Fontana; R L Commissaris
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  A risk-benefit assessment of pharmacological treatments for panic disorder.

Authors:  J A Bennett; M Moioffer; S P Stanton; M Dwight; P E Keck
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

8.  Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Authors:  Christiaan H Vinkers; Berend Olivier
Journal:  Adv Pharmacol Sci       Date:  2012-03-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.